Bonraybio Co., Ltd. Stock Price

TWSE:6955 Community·NT$2.9b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Author Program NEW Create Narrative

6955 Share Price Performance

NT$0

-137.14 (-100.00%)

NT$0

-137.14 (-100.00%)

NT$0

Mon, 21 Sep 26

Share Pricen/a

6955 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

No trending discussion available.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks

2 Rewards

View Full Analysis

Bonraybio Co., Ltd. Key Details

Last Reported Earnings

Jun 30, 2026

Next Reporting Earnings

n/a

: 3.55
: 77.37%
: 32.50%
: 0%

View Full Analysis

About 6955

Founded: 2015
Employees: n/a
CEO: Zhenteng Xu
WebsiteView website: bonraybio.com

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.